FDA Grants Third Emergency-Use Authorization For H7N9 Flu Test
This article was originally published in The Gray Sheet
Executive Summary
The April 25 emergency authorization covers the use of Arbor Vita Corp.’s rapid H7N9 assay in government laboratories on U.S. citizens who are suspected of exposure to the variant of avian flu in China.